We report the regional variation in [3H]nimodipine binding in vivo during focal cerebral isch emia. After intravenous injection, 30 min of circulation of eH]nimodipine was sufficient to establish a secular equi librium of distribution in the brain. Rats sustained left middle cerebral and common carotid artery occlusions for 5 min, and 4, 24, and 48 h (n ?o 6 per group). They were decapitated 30 min after injection of 250 /l-Ci of eH]nimodipine and their brains were submitted to auto radiography. The concentrations of r3Hjnimodipine in plasma and brain structures, corrected for metabolism of nimodipine, were used to calculate the regional volumes Correlating these data with CBF and histologic determi nations performed in separate groups of rats, we conclude that eH]nimodipine binding increases earlier in the more severely ischemic structures than in those with more moderate reductions in perfusion. Furthermore, when binding declines in a region where it was previously in creased, infarction is likely. These studies afford new in sight into the concept of ischemic penumbra and suggest that this model may allow testing for therapeutic effec tiveness.
0.025, 0.137 ± 0.056*, -0.201 ± 0.367, and -0.049 ± 0.370 (mean ± SD, *represents p < 0.01 compared with controls). By contrast, in the superior frontal cortex, val ues for log (V LIV R) in the same sequence were -0. 0\ 6 ± 0.025, 0.028 ± 0.056, 0.284 ± 0.228*, and 0.224 ± 0.069*, thus showing a significant rise in eH]nimodipine binding only at 4 h. Structures such as the cingulate and striate cortex, sufficiently removed from the ischemic core, showed only small changes in log (V L 1V R) at all times.
Correlating these data with CBF and histologic determi nations performed in separate groups of rats, we conclude that eH]nimodipine binding increases earlier in the more severely ischemic structures than in those with more moderate reductions in perfusion. Furthermore, when binding declines in a region where it was previously in creased, infarction is likely. These studies afford new in sight into the concept of ischemic penumbra and suggest that this model may allow testing for therapeutic effec tiveness. Key Words: Nimodipine binding-Cerebral isch emia.
emic tissue that may survive. These concepts have limited practical application because postischemic CBP, at least in the acute phase, is an unreliable index of tissue viability: it can be extremely low as in "no-reflow" (Ginsberg et aI., 1978; Hossmann, 1982; Kagstrom et aI., 1983) or it can be unneces sarily high in lUXury perfusion when CBP exceeds the metabolic needs of the tissue (Traupe et aI., 1982; Olsen and Lassen, 1984) . Therefore, it has increasingly become necessary to characterize isch emic severity and predict tissue survival not only on the basis of perfusion but as a function of changes in basic membrane properties.
We reasoned that the binding properties of cal cium channels may reveal the ultimate fate of pre viously ischemic tissue. Anoxia of brain tissue is accompanied by marked reduction of the extracel lular calcium concentration (Hansen, 1985; Siesjo and Wielock, 1985) . The intracellular accumulation of calcium may be the final common path leading to necrosis of the neurons exposed to anoxia (Choi, 1985; Siesj6 and Bengsston, 1989) . Because calcium moves through specific membrane channels (Miller, 1987) that permit the transfer of Ca2+ ions across membranes, we aimed at measuring the binding ca pacity of calcium channels as an indicator of the physiologic state of the neurons. Toward this goal, we used quantitative autoradiography to study the binding of a dihydropyridine to calcium channels in vivo, using nimodipine as the ligand. We defined the time course of nimodipine binding after focal ischemia, related regional differences in this binding to the CBF, and compared the regional differences to the histologic outcome. The findings reveal that eH]nimodipine binding is activated earlier in the more severely ischemic brain regions and more slowly in regions where the decrease in CBF is not severe, thus permitting an assessment of the sever ity of the exposure of the tissue to ischemia. We conclude that these studies may identify ischemic tissue that can still survive and hence permit an evaluation of the response to therapy.
MATERIALS AND METHODS

Ischemia model
We performed all measurements in male Sprague Dawley rats (250 g) that were allowed to breathe unas sisted throughout the studies. With animals under halo thane anesthesia, the method of Tamura et al. (1981) was used to expose the left middle cerebral artery (MCA). The ipsilateral common carotid artery (CCA) was also ex posed. Ischemia was produced by cautery of the MCA proximal to the olfactory tract followed immediately by ligation of the CCA. The arterial occlusions were main tained until the animals were killed 5 min, or 4, 24, or 48 h later. In the latter two groups, a second short interval of anesthesia was necessary to place catheters in one fem oral vein and artery approximately 4 h before decapita tion to allow blood sampling and measurement of the an imals' physiologic status. Controls were either normal an imals in which femoral catheters were placed but no cranial or neck surgery was performed (normal controls) or sham-operated animals in which all surgical proce dures were completed except for cautery of the vessels. In the last group, a region of pia free of any visible vessels was "cauterized" for as long as the vessels in the isch emic group were.
Physiological variables
In every rat, measurements of rectal temperature, mean arterial blood pressure (MABP), arterial blood gases (ABO) and plasma pH were obtained. Plasma glu cose concentration was not measured but all rats were fasted overnight. In animals killed at 5 min after the MCA + CCA occlusion, MABP and rectal temperature were monitored constantly after the occlusion, but the remain ing variables could not be measured before decapitation. For all other durations of occlusion, two ABO measurements were made 3 ha nd 1 h before decapitation while BP and temperature were monitored constantly in that interval.
CBF measurements
We used the method of Sakurada et al. (1978) to deter mine CBF in separate groups of at least five rats at each of the above intervals after MCA + CCA occlusion as well as in normal controls. At 1 min before decapitation, 30 ILCi of [14C]iodoantipyrine (lAP; sp act 55 mCilmmol; Amersham) was injected intravenously in 1.8 ml saline. The injection was programmed to result in a linear rise of P4C]IAP activity in free-flowing arterial blood sampled from an arterial catheter. On decapitation 1 min later, the brain was removed and frozen with liquid nitrogen. Twenty-micrometer sections were exposed to radio graphic film (Kodak SB-5, Picker International, Mon treal, Canada) for 3 days. Tissue P4C]IAP content was measured with a microcomputer imaging device (MCID, Imaging Research Inc., St-Catharines, Ontario, Canada) in regions of interest (RO!) defined by templates (see be low). The activity of each ROI was determined in at least three different sections and was averaged.
Measurement of [ 3 H]nimodipine binding
Before studying the effect of ischemic duration on ni modipine binding, we determined the concentration of nimodipine and its metabolites in blood and brain, defined the conditions necessary for binding equilibrium to per tain, and determined the specificity and saturability of the channel-ligand interaction. These studies are presented fully in the companion article (Hogan et aI., 1991) .
Effect of ischemic duration
Binding of [3H]nimodipine was measured in the brains of six groups of animals: normal controls (n = 3), sham operated controls (n = 3), and rats in which the MCA + CCA had been occluded for 5 min, and 4, 24, and 48 h (n ?o 6 in each group). Regardless of ischemic duration, all rats were infused continuously for 3 min with 250 ILCi of [3H]nimodipine intravenously. The infusion volume was 600 ILl, composed of 250 ILl ethanol:350 ILL carrier (BAY e9736-placebo) given 30 min before decapitation. Thus, all brains were exposed to comparable concentrations of nimodipine and its metabolites. In the rats ischemic for 5 min, the injection of nimodipine preceded the occlusion of the vessels by 25 min. Plasma samples were obtained at decapitation and the brains were removed and processed for autoradiography as for CBF determinations above. Approximately 92 slices from each rat were exposed to film. This was done in each rat by discarding systemati cally six sections and capturing the seventh for measure ment of r3H]nimodipine concentration. After every sixth slice obtained for this determination, the immediately ad jacent slice was removed for histologic examination.
The cerebral regions at which eH]nimodipine or P4C]IAP concentrations were measured were standard ized. Five coronal levels were chosen and subdivided into symmetrical ROIs representing ischemic and mirror image contralateral regions within which we measured the cerebral radioactivities ( Fig. 1, right side) . In each rat, the autoradiographic brain sections most closely match ing these templates were then selected, the templates were modified to fit the individual anatomy, and the ac tivity in the different ROIs was read and compared with standards exposed with the brain. Each brain structure was analyzed in at least three sections and the average was used to represent the concentration in that ROI. For eH]nimodipine, the volume of distribution (V) of the ligand in each ROI on the ischemic (left, L) hemisphere, considered to represent total binding, was compared with the activity in the contralateral (right, R) mirror-image ROI where the binding was considered nonspecific. The ratio of the concentration (V L/V R) was obtained and its logarithm was calculated. This transformation is intended to convert multiplicative factor effects into additive ones. The transformation may also convert a skewed distribu tion into a symmetrical one (Zar. 1984) . For the grouP. the mean of the logarithm was calculated as 2.7� I 10g lO (V L/V RJ/n, where n is the number of animals in the group.
Histologic examination
Approximately 16 brain sections were obtained from every rat receiving [3H]nimodipine for histologic exami nation. Brain sections immediately adjacent to those ob tained for autoradiography were removed, mounted, stained with cresyl violet, and submitted to a pathologist who was not aware of the experimental details. The pres ence of frank infarction in brain sections examined was noted and the regions affected were outlined on the tem plates.
RESULTS
Characteristics of cerebral nimodipine binding
Full details of these measurements are reported in the companion article (Hogan et aI., 1991) . Gas chromatographic determination of nimodipine con centration in the brain and plasma after infusion of J Cereb Blood Flow Me/ab, Vol. n, No.5, 199/ a mixture of tritiated and unlabeled nimodipine showed that it is actively metabolized in both sys tems. Thirty minutes after infusion, the fraction of the observed radioactivity that remained as unme tabolized nimodipine in the plasma was 30% and in the brain was 73%. There was no significant differ ence in these fractions between ischemic and non ischemic hemispheres. These values were used to correct plasma nimodipine concentration and the autoradiographic measurements obtained in the subsequent experiments.
Equilibrium studies showed that after 30 min of circulation, the distribution of nimodipine in the brain had reached secular equilibrium. Further more, [3H]nimodipine binding in the brain was spe cific and saturable.
Effect of ischemic duration on [ 3 H]nimodipine binding
Physiologic variables. Table 1 shows the last re corded MABP, arterial blood gases, and rectal tem perature at the various durations of ischemia. Be cause of the time constraints, arterial blood gas measurements could not be made in the rats oc cluded for 5 min. In this group, the MABP was significantly lower than in the controls, likely be cause these animals were still anesthetized. Other wise, there were no significant differences in the of the caudate-putamen, showed increased binding. There was generalized decline in nimodipine bind ing activity in all structures between 24 and 48 h of ischemia.
A K-means cluster analysis (Hartigan and Wong, 1979 ) was performed on L7=1 10gJO(VdVR)/n in 33
ROIs for 2-10 clusters measured on five variables representing the control animals (both normal and sham operated) and the four durations of MCA + CCA occlusion. A plot of the sum of the squares of the distances of points to the center of each cluster against the number of clusters showed that there was a gradual improvement in this parameter with increasing number of clusters. A grouping of four clusters was chosen and their distribution is shown in Fig. 1 , left side. All F ratios were higher than 20. The characteristics of the four clusters are shown in Fig. 3 and can be summarized as follows. In clus ter 1 (shown in black in Fig. 1 ), although mean log (V L/V R) is significantly higher than control at 5 min, it rises by 4 h of ischemia to much higher values and declines only after 24 h of ischemia. By contrast, in cluster 4, identified in Fig. 1 by horizontal lines, mean log (VdVR) is highest at 5 min of ischemia and declines subsequently. The lateral caudate (level 2, structure 7 in Fig. 1 ) is a typical structure in this cluster. Cluster 2 (vertical lines, Fig. 1 ), which in cludes regions such as the cingulate gyrus and hip pocampus, which are not affected by ischemia in this model, has low mean 10g(VL/VR) values throughout. Cluster 3 represents the regions under lying the cautery sites and shows that both control and ischemic animals have at all times elevated log (VdVR) in these areas. There were no significant differences among the mean 10g(VL/VR) values in cluster 3. The rate of decline of nimodipine binding from the peak was variable. In the lateral caudate, the activity at 4 h was lower in the ischemic region than in the contralateral hemisphere. The overlying cor tex showed a more gradual decline of its eH]ni modi pine content. were selected as representatives of the different patterns of eHlnimodipine binding after ischemia as identified by the cluster analysis. It can be seen that the lateral caudate, which in this model shows early increase in nimodipine binding, has the most severe depression in CBP and shows histologically evident infarction by 4 h. In contrast, the frontal cortex, which shows a later increase in nimodipine binding, has a more moderate decline in CBP, and it is only at 24 h after occlusion that infarction in it is evident.
DISCUSSION
In this report, an in vivo quantitative autoradio graphic method was used to measure eH]nimo dipine binding in normal and ischemic rat brain. Our main conclusion is that eHlnimodipine binding to the brain increases with ischemia, with the binding increasing rapidly in regions with severe depression in CBP and more slowly in regions with a more moderate decline in perfusion. Thus, the onset of increased eHlnimodipine binding in any brain re gion reflects both the severity and the duration of blood flow reduction. Cluster analysis of our bind ing data, shown on the left side of Pig. 1, indicates the presence of a limited number of binding pat terns, but their location suggests that increased ni modi pine binding may identify regions that are vul nerable to infarct but may still be potentially sal vageable. In the lateral striatum, CBP fell to 6% of control, and a rapid increase in nimodipine binding to 148% of control values had already occurred by 5 min of oligemia. Subsequently, the binding of eHlnimodipine in this region rapidly declined, showing less eHlnimodipine content than in the contralateral hemisphere at 4 h when infarction be came evident. Cluster 1 regions, on the other hand, which included the frontal and parietal cortices, showed more gradual rises in eHlnimodipine bind ing commensurate with the moderate decline in their perfusion. The superior frontal cortex, a mem ber of this cluster whose CBP at 5 min was 20% of control, showed little increased binding at that time, but by 4 h binding had reached 175% of control values. This intense binding persisted until 24 h of ischemia, when many regions in cluster 1 showed evident infarction, confirming other evidence that calcium channels can remain physiologically active after tissue disruption (Rosenberg et aI., 1986) . Thus, a regional increase in the binding of eHlni modi pine in response to ischemia indicates vulner ability to infarction, but the subsequent decline in this parameter, although it implies that infarction is likely to occur, does not coincide with it.
The most likely explanation for our findings is that nimodipine binding to cerebral tissue increases with depolarization, which occurs more rapidly in the severely ischemic region than in the overlying cortex. The affinity (Kokubun et aI., 1986) or den sity (Kamp and Miller, 1987) of sites binding 1,4-dihydropyridine in cardiac cells increased with in creasing depolarization, and the rate of depolariza tion and 45Ca uptake into astrocytes (and neurons) was more rapid at higher extracellular K + concen trations (Hertz et aI., 1989) . In regions of severe ischemia, extracellular concentrations of K + can reach 100 mM, resulting in very rapid depolariza tion, but the levels of extracellular K + in the isch emic penumbra (4-10 mM) are also sufficient to in duce calcium ion movements (Peters, 1986) , albeit more slowly. Shimada et al. (1989) have shown that when CBP in the cat falls below �20 mll100 g/min, extracellular glutamate concentration rises sharply, an event that also leads to movements of calcium intracellularly (Pumain and Heinemann, 1985) and implies activation of the calcium channels. Thus, we believe that in the densely ischemic regions (cluster 4), the dihydropyridine-binding L-type cal cium channels show early increased binding be cause a variety of pathophysiologic events lead to the opening of the voltage-sensitive calcium chan nels. The same occurs in the moderately ischemic region of cluster 1 at a later time. This event implies movement of calcium into cells and heralds impend ing infarction.
Because of the in vivo nature of this work, sev eral factors may have influenced our binding data. We determined the rate of metabolism of the ligand in both plasma and the brain and used the data to correct the radioactivities measured in those com partments (see Hogan et aI., 1991) . Despite active metabolism, secular equilibrium of distribution of nimodipine between the brain and plasma probably was reached in less than the 30 min we imposed between administration of ligand and the autora diographic studies. Had we conducted our studies at an earlier time after ligand infusion, our binding signals would have been more intense. The negative (V LIV R) value in the lateral caudate at intervals longer than 5 min may not have a single interpreta tion. This structure was the most severely ischemic in this model, its average CBF value being 6.7 mIl 100 g/min at 5 min. Thus, the binding data imply that severe ischemia reduces in time not only total but also nonspecific binding. Alternatively, CBF at 5 min may be sufficient to deliver the ligand, but in the interval between 5 min and 4 h after occlusion it may decline to values that do not permit continued delivery. Thus, it is possible that the decline in eH]nimodipine binding in the lateral caudate is made artifactually more rapid by the low CBF to this region. Finally, it is possible that cerebral edema in this region eventually impairs the marginal delivery of ligand through cellular swelling.
It is unlikely that blood-brain barrier (BBB) changes contributed to our findings substantially. Nimodipine is highly lipophilic (Mason et aI., 1990) and its volume of distribution in normal cerebral cortex has been reported to be 1.64 mllg (Van den Kerckhoff and Drewes, 1985) . Using a small amino acid, we have shown that permeability of the BBB is slightly elevated after 4 h of ischemia (Hogan et aI., 1990) , in agreement with other studies of BBB function in focal ischemia (Abe et aI., 1988; Hata shita and Hoff, 1988) . The observation that eH]ni modipine binding remained low in these regions af ter 4 h of ischemia, despite these BBB changes, suggests that the barrier is not a significant one in this model.
We believe that the regionally differentiated bind-
ing levels of eH]nimodipine in the ischemic brain reflect the probability of opening of voltage sensitive L-type calcium channels located on the neuronal plasma membranes. In contrast to the re ported binding of dihydropyridines to the normal brain in vitro, where regional differences are evi dent (Gould et aI., 1985) , our in vivo studies show that nimodipine fails to bind significantly to any re gion of the normal hemisphere. This confirms the studies showing that the L-channel, in the polarized resting state, has low affinity for binding (Boland and Dingeldine, 1990) . Previous ligand binding stud ies have identified the plasma membrane as the lo cation of the high-affinity binding sites. It is con ceivable that in addition to the neurons, vascular smooth-muscle cells and glia contribute to the bind ing we measure. Microvessels isolated from rat brain increase their 45Ca influx when depolarized by KCl and contain voltage-dependent binding sites for dihydropyridine antagonists (Morel and Godfraind, 1990) . In contrast, endothelial cells of larger vessels appear to have only nonspecific low-affinity binding sites for PN-200-110 (Vanhoutte, 1988; Whitmer et aI., 1988) . The binding affinity of ( + )PN-200-110 for brain synaptosomes (Rampe et aI., 1987) and of ni modi pine for dorsal root ganglion cells (McCarthy, 1989) are similar to that reported for depolarized microvessels (for review, see Triggle et aI., 1989) . Despite these reports, we believe that eH]nimo dipine binding to microvessels is not contributing significantly to our measurements. Roland and col leagues (1990) injected cold nifedipine and nimo dipine into volunteers who had received e IC]nimo dipine and showed that the specific binding of this ligand originated from the brain and not the vascu lature. Furthermore, preliminary radioautography studies we have performed with eH]nimodipine in our rats show little or no labeling over vascular structures (Hakim and Hogan, unpublished obser vations) . Finally, our work offers a new definition of the ischemic penumbra in terms of calcium conduc tance and may therefore have important implica tions for the therapy of the ischemic brain. As de picted schematically in Fig. 4 , the calcium channels in every ischemic brain region go through a cycle of activation and inactivation before infarction. Thus, we suggest that the penumbra is not an anatomical space in the ischemic brain but rather a dynamic phase through which ischemic brain regions pass in their progression to infarction. After 5 min of isch emia, the lateral caudate is the penumbra and re mains in this phase a short while, during which its voltage-sensitive calcium channels are open and calcium moves intracellularly, leading subsequently to its infarction. The surrounding cortex enters a penumbra phase later, but it remains in this vulner able state longer. Regions such as the medial cau date, which increased eH]nimodipine binding later still (Fig. 2) , may become vulnerable to infarction only 24 h after occlusion. Thus, a very dynamic picture of infarction emerges with waves of in creased eH]nimodipine binding occurring region ally in response to both severity and duration of ischemia and heralding entry of the regions into a vulnerable phase. As the region is irreversibly dam aged, eH]nimodipine binding declines. This work does not address reversibility, but it is our hypoth esis that either arrest of the ischemia or the addition of therapy early during the phase of increased [3H]nimodipine binding may reduce it to levels com parable to that in normal tissue and reverse the pro gression to infarction. Work is now ongoing to test this hypothesis. It should allow us to show whether binding studies with nimodipine can indicate whether the opportunity to treat is still available and whether a given therapy is useful.
